Glycans in Diseases & Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a mechanism employed by cells of the immune system via sugar-binding proteins called lectins, which recognize specific carbohydrate moieties. Glycans (carbohydrate oligomers) are the “building blocks” of carbohydrates, nucleic acids, proteins and lipids which play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology or glycochemistry approach to be used.

 

  • Congenital disorders of glycosylation (CDG)
  • Transfusion medicine
  • Glycomedicine
  • Cardiac arrest
  • Cancer associated coagulopathies
  • Cardiovascular diseases
  • Cancer biomarkers

Related Conference of Glycans in Diseases & Therapeutics

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Glycans in Diseases & Therapeutics Conference Speakers